Free Trial

First Trust Advisors LP Has $163.39 Million Stock Holdings in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

First Trust Advisors LP lessened its stake in Genpact Limited (NYSE:G - Free Report) by 1.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 3,804,297 shares of the business services provider's stock after selling 47,017 shares during the quarter. First Trust Advisors LP owned 2.16% of Genpact worth $163,394,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in G. Stifel Financial Corp purchased a new stake in Genpact in the third quarter valued at approximately $1,197,000. Blue Trust Inc. increased its position in shares of Genpact by 8.7% in the fourth quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock valued at $217,000 after buying an additional 441 shares in the last quarter. Burney Co. raised its position in shares of Genpact by 242.8% during the 4th quarter. Burney Co. now owns 130,798 shares of the business services provider's stock worth $5,618,000 after purchasing an additional 92,641 shares during the last quarter. KBC Group NV purchased a new stake in shares of Genpact in the fourth quarter valued at $298,000. Finally, JPMorgan Chase & Co. boosted its stake in shares of Genpact by 192.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock worth $122,701,000 after purchasing an additional 2,060,595 shares during the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Genpact

In related news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. This represents a 4.20 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 2.80% of the company's stock.

Analyst Ratings Changes

A number of brokerages have weighed in on G. Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and increased their price target for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and lifted their price target for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Mizuho raised their target price on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Finally, Needham & Company LLC boosted their price objective on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Five investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $50.38.

Get Our Latest Analysis on Genpact

Genpact Stock Up 0.3 %

NYSE G traded up $0.17 during trading hours on Friday, reaching $47.99. 190,454 shares of the company traded hands, compared to its average volume of 1,341,359. The company has a 50 day moving average of $49.90 and a two-hundred day moving average of $46.25. The stock has a market capitalization of $8.43 billion, a PE ratio of 16.89, a PEG ratio of 1.84 and a beta of 1.06. Genpact Limited has a 12 month low of $30.38 and a 12 month high of $56.76. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.

Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, equities analysts expect that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th were given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date of this dividend was Tuesday, March 11th. This is an increase from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio is currently 23.94%.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines